coronavirus%20disease%202019%20(covid-19)
CORONAVIRUS DISEASE 2019 (COVID-19)
Treatment Guideline Chart

It is a viral infection of the respiratory tract caused by a newly emergent coronavirus, SARS-CoV-2, that was recognized in Wuhan, China in December 2019.

Mode of transmission is through contact and droplet via direct, indirect or close contact with infected individuals through secretions ie saliva and respiratory secretions.

Generally, after exposure to the virus, the mean time to develop symptoms is 4-6 days, with a range of between 1 and 14 days.

Coronavirus Disease 2019 (COVID-19) References

  1. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Accessed 22 Feb 2021. PMID: 32200663
  2. Iqbal Z, Ho JH, Adam S, et al. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: an expert panel position statement from HEART UK. Atherosclerosis. 2020 Nov;313:126-136. doi: 10.1016/j.atherosclerosis.2020.09.008. Accessed 18 Jan 2021. PMID: 33045618
  3. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020 Dec;S1473-3099(20):30847-1. doi: 10.1016/S1473-3099(20)30847-1. Accessed 04 Apr 2021. PMID: 33333012
  4. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. 20 Apr 2023. Accessed 10 Apr 2022.
  5. Institute of Clinical Epidemiology, National Institutes of Health, UP Manila, Philippine Society for Microbiology and Infectious Diseases. Philippine COVID-19 Living Recommendations as of 09 May 2021. PSMID. https://www.psmid.org/.
  6. McIntosh K. COVID-19: Epidemiology, virology, and prevention. UpToDate. https://www.uptodate.com. 14 May 2021.
  7. World Health Organization. Tracking SARS-CoV-2 variants. WHO. https://www.who.int. 31 May 2021. Accessed 02 Jun 2021.
  8. Ng KE, Rickard JP. The effect of COVID-19 on patients with diabetes. US Pharm. 2020 Nov;45(11):9-12. https://www.uspharmacist.com. Accessed 14 Jan 2021
  9. American Diabetes Association. How COVID-19 impacts people with diabetes. ADA. https://www.diabetes.org/. Jan 2021.
  10. American Society for Reproductive Medicine. American Society for Reproductive Medicine (ASRM) patient management and clinical recommendations during the coronavirus (COVID-19) pandemic. Update no. 11 – COVID-19 vaccination. ASRM. https://www.asrm.org. 16 Dec 2020.
  11. Ang MC, Binas V, Kasala MC, et al. Position statements of the Philippine Society of Allergy, Asthma, and Immunology on COVID-19 vaccines and their adverse reactions. Philippine Pediatric Society (PPS). https://pps.org.ph/. 01 Feb 2021. Accessed 16 Feb 2021.
  12. Apicella M, Campopiano MC, Mantuano M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792. doi: 10.1016/S2213-8587(20)30238-2. PMID: 32687793
  13. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020 Apr:ciaa478. doi: 10.1093/cid/ciaa478. PMID: 32338708
  14. Caliendo AM, Hanson KE. Coronavirus disease 2019 (COVID-19): diagnosis. UpToDate. https://www.uptodate.com. 30 Oct 2020.
  15. Centers for Disease Control and Prevention. Duration of isolation and precautions for adults with COVID-19. CDC. https://www.cdc.gov/. 19 Oct 2020. Accessed 04 Jan 2021.
  16. Centers for Disease Control and Prevention. How to select and use hand sanitizer. CDC. https://www.cdc.gov/. 25 Nov 2020. Accessed 07 Dec 2020..
  17. Centers for Disease Control and Prevention. How to select, wear, and clean your masks. CDC. https://www.cdc.gov/. 27 Nov 2020.
  18. Centers for Disease Control and Prevention. Interim: clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). CDC. https://www.cdc.gov/. 08 Dec 2020. Accessed 19 Jan 2021.
  19. Centers for Disease Control and Prevention. Interim: implications of the Emerging SARS-CoV-2 Variant VOC 202012/01. CDC. https://www.cdc.gov/. 29 Dec 2020. Accessed 11 Jan 2021.
  20. Centers for Disease Control and Prevention. Interim: infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. CDC. https://www.cdc.gov/. 14 Dec 2020. Accessed 21 Dec 2020.
  21. Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) interim guidance. CDC. https://www.cdc.gov/. 14 May 2020.
  22. Centers for Disease Control and Prevention. Social distancing. CDC. https://www.cdc.gov/. 17 Nov 2020. Accessed 14 Jan 2021.
  23. Centers for Disease Control and Prevention. People with certain medical conditions. CDC. https://www.cdc.gov/. 29 Dec 2020.
  24. Centers for Disease Control and Prevention. Understanding how COVID-19 vaccines work. CDC. https://www.cdc.gov/. 02 Nov 2020.
  25. Centers for Disease Control and Prevention. Understanding mRNA COVID-19 vaccines. CDC. https://www.cdc.gov/. 23 Nov 2020.
  26. Centers for Disease Control and Prevention. Ventilation in buildings. CDC. https://www.cdc.gov/. 09 Feb 2020.
  27. Feld JJ, Kandel C, Biondi MJ, et al. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med. 2021 Feb;S2213-2600(20)30566-X. doi: 10.1016/S2213- 2600(20)30566-X. PMID: 33556319
  28. Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, et al. Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: a cross-sectional a population based study. Compr Psychiatry. 2021 Jan;104:152214. doi: 10.1016/j.comppsych.2020.152214. PMID: 33186837
  29. Global Initiative for Asthma (GINA). Interim guidance about COVID-19 and asthma. GINA global strategy for asthma management and prevention. GINA. https://www.ginasthma.org. 20 Dec 2020.
  30. Healthcare Professionals Alliance Against COVID-19 (HPAAC). Unified COVID-19 algorithms. PSMID. https://www.psmid.org. 07 Nov 2020.
  31. Hung IF, Lung KC, Tso EY, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. PMID: 32401715
  32. Kanwal A, Agarwala A, Martin LW, et al. COVID-19 and hypertension: what we know and don’t know. American College of Cardiology (ACC). https://www.acc.org/. 06 Jul 2020.
  33. Kim AY, Gandhi RT. Coronavirus disease 2019 (COVID-19): management in hospitalized adults. UpToDate. https://www.uptodate.com. 11 Feb 2021.
  34. Liang T. Handbook of COVID-19 prevention and treatment. Zhejiang University School of Medicine. http://www.zju.edu.cn/. 18 Mar 2020.
  35. Mai F, Del Pinto R, Ferri C. COVID-19 and cardiovascular diseases. Journal of Cardiology. 2020 Jul;76(5):453–458. doi: 10.1016/j.jjcc.2020.07.013. PMID: 32736906
  36. McIntosh K. Coronavirus disease 2019 (COVID-19): clinical features. UpToDate. https://www.uptodate.com. 28 Oct 2020.
  37. Medicines and Healthcare products Regulatory Agency. Information for healthcare professionals on COVID-19 vaccine AstraZeneca. Gov UK. https://www.gov.uk/. 07 Jan 2021. Accessed 18 Jan 2021.
  38. Ministry of Health Malaysia. Clinical management of confirmed COVID-19 case in adult and paediatric, annex 2e. MOH (Malaysia). http://covid-19.moh.gov.my/. 13 Aug 2021. Accessed 18 Apr 2022.
  39. National Institute of Health. Coronavirus Disease 2019 (COVID-19) treatment guidelines. NIH. https://www.covid19treatmentguidelines.nih.gov/. 18 Aug 2022. Accessed 16 Feb 2021.
  40. Pan American Health Organization and World Health Organization. Infographic: COVID-19 compared to other diseases and conditions. PAHO. https://www.paho.org/. 05 Jun 2020.
  41. Philippine Society for Microbiology and Infectious Diseases, Philippine College of Chest Physicians, Philippine College of Physicians, Philippine Rheumatology Association, Philippine College of Hematology and Transfusion Medicine. Interim guidance on the clinical management of adult patients with suspected or confirmed COVID-19 infection version 3.1 as of July 20, 2020. PSMID. https://www.psmid.org/. 20 Jul 2020.
  42. Radencovic D, Chawla S, Pirro M, et al. Cholesterol in relation to COVID-19: should we care about it. J Clin Med. 2020 Jun;9(6):1909. doi: 10.3390/jcm9061909. PMID: 32570882
  43. Rawat K, Kumari P, Saha L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. 2021 Feb;892:173751. doi: 10.1016/j. ejphar.2020.173751. PMID: 33245898
  44. Siegel M. Acute respiratory distress syndrome: clinical features, diagnosis, and complications in adults. UpToDate. https://www.uptodate.com. 13 Mar 2020. Accessed 06 Nov 2020.
  45. Son MB, Friedman K. Coronavirus disease 2019 (COVID-19): multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. UpToDate. https://www.uptodate.com. 25 Sep 2020. Accessed 06 Nov 2020.
  46. Son MB, Friedman K. Coronavirus disease 2019 (COVID-19): multisystem inflammatory syndrome in children (MIS-C) management and outcome. UpToDate. https://www.uptodate.com. 25 Sep 2020.
  47. US Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EAU) of the Moderna COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). US FDA. https://www.fda.gov. Dec 2020.
  48. US Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EAU) of the Pfizer-Biontech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). US FDA. https://www.fda.gov. Dec 2020.
  49. World Health Organization. Clinical management of COVID-19 interim guidance. WHO. https://www.who.int/. 27 May 2020.
  50. World Health Organization. Coronavirus disease (COVID-19): ventilation and air-conditioning in public spaces and buildings. WHO. https://www.who.int/. 29 Jul 2020.
  51. World Health Organization. Criteria for releasing COVID-19 patients from isolation. WHO. https://www.who.int/. 17 Jun 2020.
  52. World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance. WHO. https://www.who.int/. 11 Sep 2020. Accessed 06 Nov 2020.
  53. World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief. WHO. https://www.who.int/. 09 Jul 2020.
  54. World Health Organization. WHO Coronavirus Disease (COVID-19) dashboard. WHO. https://covid19.who.int/. 12 Oct 2023. Accessed 23 May 2023.
  55. World Health Organization. WHO recommends follow-up care, low-dose anticoagulants for COVID-19 patients. WHO. https://www.who.int/. 27 Jan 2021.
  56. World Health Organization. Coronavirus disease (COVID-19): masks. WHO. https://www.who.int/. 01 Dec 2020.
  57. World Health Organization. Draft landscape of COVID-19 candidate vaccines. WHO. https://www.who.int/. 05 Jan 2021.
  58. World Health Organization. WHO Saves Lives: clean your hands in the context of COVID-19. WHO. https://www.who.int/. 05 May 2020. Accessed 07 Dec 2020.
  59. Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet. 17 Nov 2020. https://www.thelancet.com/.
  60. World Health Organization. Tracking SARS-CoV-2 variants. WHO. https://www.who.int/. 17 Aug 2023. Accessed 23 May 2023.
  61. National Institute of Health. Coronavirus Disease 2019 (COVID-19) treatment guidelines. NIH. https://www.covid19treatmentguidelines.nih.gov/. Aug 2021. Accessed 24 Aug 2021.
  62. Centers for Disease Control and Prevention. COVID-19 vaccine booster shot. Centers for Disease Control and Prevention. https://www.cdc.gov. 01 Sep 2021.
  63. Vogel L, Duong D. What's the evidence for COVID-19 booster shots. CMAJ. 2021;193(35):E1400-E1401. doi: 10.1503/cmaj.1095959. PMID: 34493570
  64. World Health Organization. Interim statement on COVID-19 vaccine booster doses. World Health Organization. https://www.who.int. 10 Aug 2021.
  65. Centers for Disease Control and Prevention. COVID-19 vaccines for children and teens. CDC. https://www.cdc.gov/. 4 Nov 2021.
  66. Centers for Disease Control and Prevention. COVID-19 vaccines for moderately to severely immunocompromised people. CDC. https://www.cdc.gov/. 18 Oct 2021.
  67. Centers for Disease Control and Prevention. Ending isolation and precautions for people with COVID-19: interim guidance. CDC. https://www.cdc.gov/. 14 Sep 2021.
  68. Centers for Disease Control and Prevention. Quarantine and isolation. CDC. https://www.cdc.gov/. 20 Jan 2022.
  69. Mikkelsen ME, Abramoff B.. COVID-19: Evaluation and management of adults following acute viral illness. UpToDate. https://www.uptodate.com. 21 Dec 2021.
  70. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE. https://www.nice.org.uk. 13 Dec 2021.
  71. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19 version 8.0. IDSA. https://www.idsociety.org/. 23 Mar 2022.
  72. World Health Organization. Therapeutics and COVID-19: living guideline. WHO. https://www.who.int/. 16 Sep 2022. Accessed 02 May 2022.
  73. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. 06 Mar 2023. Accessed 15 Mar 2023.
  74. World Health Organization. Clinical management of COVID-19: living guideline. WHO. https://www.who.int/publications/. 13 Jan 2023.
  75. World Health Organization. Therapeutics and COVID-19: living guideline. WHO. https://www.who.int/. 13 Jan 2023.
  76. World Health Organization. Updated working definitions and primary actions for SARS-CoV-2 variants, 15 March 2023. WHO. https://www.who.int/. 15 Mar 2023.
  77. US Food and Drug Administration (US FDA). FDA approves first oral antiviral for treatment of COVID-19 in adults. US FDA. https://www.fda.gov. May 2023.
  78. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. 21 Jul 2023.
  79. Lamontagne F, Agarwal A, Rochwerg B, et al. A living WHO guideline on drugs for covid-19 (update 12, published January 2023). BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379. PMID: 32887691
  80. World Health Organization (WHO). Clinical management of COVID-19: living guideline. WHO. https://www.who.int. 18 Aug 2023.
Editor's Recommendations
Special Reports